2021
DOI: 10.15360/1813-9779-2021-3-2-0
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers of Air-Blood Barrier Damage In COVID-19

Abstract: The search for sensitive and specific markers enabling timely identification of patients with a life-threatening novel coronavirus infection (COVID-19) is important for a successful treatment.The aim of the study was to examine the association of molecular biomarkers of air-blood barrier damage, surfactant proteins SP-A and SP-D and Club cell protein CC16, with the outcome of patients with COVID-19.Materials and methods. A cohort of 109 patients diagnosed with COVID-19 was retrospectively divided into two grou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 53 publications
0
1
0
Order By: Relevance
“…The study sample, as well as the inclusion and exclusion criteria, have been described in detail previously [6]. The total sample (n=109) consisted of patients discharged from ICU in stable condition (n=90) and patients with fatal outcome (n=19).…”
Section: Methodsmentioning
confidence: 99%
“…The study sample, as well as the inclusion and exclusion criteria, have been described in detail previously [6]. The total sample (n=109) consisted of patients discharged from ICU in stable condition (n=90) and patients with fatal outcome (n=19).…”
Section: Methodsmentioning
confidence: 99%